Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protein Frustration Reveals Orthosteric and Allosteric Active Sites in GPCR:G Protein Complexes.

Journal of chemical information and modeling·2026
Same author

Conserved residues in the Gα interface show subtype specificity in Gβγ coupling.

The Journal of biological chemistry·2026
Same author

DRUMBEAT temporally resolved interpretable machine learning model for characterizing state transitions in protein dynamics.

Communications biology·2026
Same author

Allostery between Distant Structural Regions Dictates Selectivity in GPCR:G Protein Coupling.

Biochemistry·2026
Same author

Conserved Residues in the Gα interface show subtype specificity in Gβγ coupling.

bioRxiv : the preprint server for biology·2026
Same author

The future of mathematical oncology in the age of AI.

NPJ systems biology and applications·2026

Related Experiment Video

Updated: May 29, 2026

CorrelationCalculator and Filigree: Tools for Data-Driven Network Analysis of Metabolomics Data
07:11

CorrelationCalculator and Filigree: Tools for Data-Driven Network Analysis of Metabolomics Data

Published on: November 10, 2023

Systems biology data analysis methodology in pharmacogenomics.

Andrei S Rodin1, Grigoriy Gogoshin, Eric Boerwinkle

  • 1Human Genetics Center, School of Public Health, University of Texas Health Science Center, Houston, TX 77030, USA. andrei.s.rodin@uth.tmc.edu

Pharmacogenomics
|September 17, 2011
PubMed
Summary

Pharmacogenetics and pharmacogenomics use genomic data to understand how genes affect drug responses and side effects. New systems biology methods are crucial for analyzing complex genetic data to advance drug discovery and personalized medicine.

Related Experiment Videos

Last Updated: May 29, 2026

CorrelationCalculator and Filigree: Tools for Data-Driven Network Analysis of Metabolomics Data
07:11

CorrelationCalculator and Filigree: Tools for Data-Driven Network Analysis of Metabolomics Data

Published on: November 10, 2023

Area of Science:

  • Genomics
  • Systems Biology
  • Pharmacogenomics

Background:

  • Pharmacogenetics investigates genetic influences on individual drug responses.
  • Advancements in high-throughput genomic technologies are driving the field towards pharmacogenomics.
  • Understanding complex biological systems is key to realizing the full potential of pharmacogenomics.

Purpose of the Study:

  • To review progress in data analysis methodologies for pharmacogenomics.
  • To highlight the application of systems biology approaches in analyzing large-scale genetic data.
  • To address the challenge of reverse-engineering biological systems from genetic epidemiology studies.

Main Methods:

  • Review of recent advancements in data analysis methodologies.
  • Application of systems biology research paradigms.
  • Focus on holistic and mechanistic understanding of biological systems.

Main Results:

  • Progress has been made in developing data analysis methods for pharmacogenomics.
  • Systems biology offers a framework for understanding complex gene-drug interactions.
  • The challenge of analyzing massive datasets from genetic studies is being addressed.

Conclusions:

  • Pharmacogenomics holds promise for personalized medicine and drug discovery.
  • Advanced data analysis and systems biology are essential for interpreting complex genomic data.
  • A holistic understanding of biological systems is critical for advancing pharmacogenomics.